Using BCG vaccination to protect against COVID-19: when reality fails to meet expectation

Nat Rev Immunol. 2024 Feb;24(2):83-84. doi: 10.1038/s41577-024-00992-z.

Laure F Pittet^{1

2

3}, Christie C A Noble^{4

5

6}, Nicole L Messina^{4

5}, Nigel Curtis^{7

8

9}

¹ Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia. laure.pittet@hcuge.ch.
² Murdoch Children's Research Institute, Parkville, Victoria, Australia. laure.pittet@hcuge.ch.
³ Immunology-Vaccinology and Paediatric Infectious Diseases Unit, Faculty of Medicine, Geneva University Hospitals, Geneva, Switzerland. laure.pittet@hcuge.ch.
⁴ Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia.
⁵ Murdoch Children's Research Institute, Parkville, Victoria, Australia.
⁶ Infectious Diseases, The Royal Children's Hospital Melbourne, Parkville, Victoria, Australia.
⁷ Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia. nigel.curtis@rch.org.au.
⁸ Murdoch Children's Research Institute, Parkville, Victoria, Australia. nigel.curtis@rch.org.au.
⁹ Infectious Diseases, The Royal Children's Hospital Melbourne, Parkville, Victoria, Australia. nigel.curtis@rch.org.au.

No abstract available

MeSH terms